A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
With a grant from NIH, the UC Davis Mouse Biology Program aims to create lab mice with aspects of the human immune system that allow them to support growth of the AIDS virus, HIV. These mice could be ...
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
HCW Biologics debuted the results from its preclinical study of HCW11-018b, the Company’s lead T-cell engager product candidate, that highlights the uniqueness and advantages of its second-generation ...
A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created ...
WILMINGTON, Del.--(BUSINESS WIRE)--GemPharmatech (GemPharmatech Co., Ltd. “GPT”) presented its humanized mouse models to support T-Cell Bispecific antibody and COVID-19 preclinic development and ...
Flow cytometry enables researchers to label proteins of interest using fluorophore-conjugated antibodies and other fluorochromes. Much like immunohistochemistry, which produces two- or ...
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms? Researchers in the lab of Yale’s Richard Flavell decided to ...
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms? Researchers in the lab of Yale's Richard Flavell decided to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback